Skip to content

Latigo Biotherapeutics, Inc.

LTGO · XNAS

CIK 2056611fmd_1WDK9G6AZ3ZS2DW5G071DYWWQRManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 7 periods

Loading statement
Latigo Biotherapeutics, Inc. (LTGO) financial statements · FinancialMD